Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test

Diabetes

Volumn 54, Issue 11, 2005, Pages 3305-3318

  Ewens, Kathryn Gogolin ^a   George, Roberta Ann ^a   Sharma, Kumar ^b   Ziyadeh, Fuad N ^a   Spielman, Richard S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 1; CATALASE; DECAPENTAPLEGIC PROTEIN; GLUTATHIONE PEROXIDASE 1; LAMININ; LAMININ ALPHA4; LAMININ GAMMA1; PROTEIN BCL 2; SMAD PROTEIN; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; UPSTREAM TRANSCRIPTION FACTOR 1;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EUROPE; FAMILY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PROCEDURES; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGENY; PROTEINURIA; PROTO ONCOGENE; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TANDEM REPEAT; TRANSMISSION DISEQUILIBRIUM TEST;

ADULT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; SAMPLE SIZE;

EID: 33644766738     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.11.3305     Document Type: Article

References (154)

1. American Diabetes Association: Diabetic nephropathy (Position Statement). Diabetes Care 26 (Suppl. 1):S94-S98, 2003
2. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
3. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
4. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
5. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945, 1996
6. Satko SG, Langefeld CD, Daeihagh P, Bowden DW, Rich SS, Freedman BI: Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 40:489-494, 2002
7. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS: Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 49:1057-1063, 2000
8. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL: Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 49:1049-1056, 2000
9. Doria A, Warram JH, Krolewski AS: Genetic susceptibility to nephropathy in insulin-dependent diabetes: from epidemiology to molecular genetics. Diabete Metab Rev 11:287-314, 1995
10. Caramori ML, Mauer M: Diabetes and nephropathy. Curr Opin Nephrol Hypertens 12:273-282, 2003
11. Dolan V, Hensey C, Brady HR: Diabetic nephropathy: renal development gone awry? Pediatr Nephrol 18:75-84, 2003
12. Lindner TH, Monks D, Wanner C, Berger M: Genetic aspects of diabetic nephropathy. Kidney Int 84 (Suppl.):S186-S191, 2003
13. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516, 1993
14. Lernmark A, Ducat L, Eisenbarth G, Ott J, Permutt MA, Rubenstein P, Spielman R: Family cell lines available for research. Am J Hum Genet 47:1028-1030, 1990
15. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF, III, Spielman RS, Dunaif A: Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A 96:8573-8578, 1999
16. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES: Parametric and non-parametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363, 1996
17. Uitenbroek DG: SISA-Binomial [article online], 1997. Available from http://home.clara.net/sisa/binomial.htm. Accessed 3 January 2005
18. Chen JW, Hansen PM, Tarnow L, Hellgren A, Deckert T, Pociot F: Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy. Diabet Med 14:143-147, 1997
19. Krolewski AS, Tryggvason K, Warram J, Laffel L, Housman D: Diabetic nephropathy and polymorphism in the gene coding for the alpha 1 chain of collagen IV. Kidney Int 37: 510, 1990
20. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47:1164-1169, 1998
21. Chowdhury TA, Dyer PH, Kumar S, Gough SC, Gibson SP, Rowe BR, Smith PR, Dronsfield MJ, Marshall SM, Mackin P, Dean JD, Morris PJ, Davies S, Dunger DB, Boulton AJ, Barnett AH, Bain SC: Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabet Med 14:837-840, 1997
22. Doria A, Onuma T, Warram JH, Krolewski AS: Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 40:1293-1299, 1997
23. Miller JA, Thai K, Scholey JW: Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes 49:1585-1589, 2000
24. Savage DA, Feeney SA, Fogarty DG, Maxwell AP: Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. Nephrol Dial Transplant 14:891-894, 1999
25. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62:963-970, 2002
26. Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS: Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus. J Am Soc Nephrol 14:2015-2024, 2003
27. Iyengar SK, Fox KA, Schachere M, Manzoor F, Slaughter ME, Covic AM, Orloff SM, Hayden PS, Olson JM, Schelling JR, Sedor JR: Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol 14:S195-S201, 2003
28. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17:384-385, 1997
29. Lindner T, Njolstad P, Horikawa Y, Bostad L, Bell G, Sovik O: A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 8:2001-2008, 1999
30. Carbone I, Cotellessa M, Barella C, Minetti C, Ghiggeri GM, Caridi G, Perfumo F, Lorini R: A novel hepatocyte nuclear factor-1beta (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes. Diabetologia 45:153-154, 2002
31. Nishigori H, Yamada S, Kohama T, Tomura H, Sho K, Horikawa Y, Bell GI, Takeuchi T, Takeda J: Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 47:1354-1355, 1998
32. Selisko T, Vcelak J, Bendlova B, Graessler J, Schwarz PE, Schulze J: Mutations and intronic variants in the HNF-1 beta gene in a group of German and Czech Caucasians with type 2 diabetes mellitus and progressive diabetic nephropathy. Exp Clin Endocrinol Diabetes 110:145-147, 2002
33. Hodgkinson AD, Millward BA, Demaine AG: Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 26:3111-3115, 2003
34. Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A, Murata M, Saruta T: Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 27:303-307, 2004
35. Maeda S, Haneda M, Guo B, Koya D, Hayashi K, Sugimoto T, Isshiki K, Yasuda H, Kashiwagi A, Kikkawa R: Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int 60:1428-1434, 2001
36. Hirakawa S, Lange EM, Colicigno CJ, Freedman BI, Rich SS, Bowden DW: Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients. Am J Kidney Dis 42:133-142, 2003
37. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I - converting enzyme gene. Diabetes 43:690-695, 1994
38. Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O, Parving HH: Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 14:2843-2850, 2003
39. Tarnow L, Gluud C, Parving HH, Nielsen FS: Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 13:1125-1130, 1998
40. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P: Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 60:46-54, 2001
41. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585-1595, 1997
42. Gilbert RE, Krum H, Wilkinson-Berka J, Kelly DJ: The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations. Diabet Med 20:607-621, 2003
43. Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M: Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 12:541-549, 2001
44. Boright AP, Paterson AD, Mirea L, Bull SB, Mowjoodi A, Scherer SW, Zinman B: Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes 54:1238-1244, 2005
45. Heesom AE, Hibberd ML, Millward A, Demaine AG: Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 46:287-291, 1997
46. Hodgkinson AD, Sondergaard KL, Yang B, Cross DF, Millward BA, Demaine AG: Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney Int 60:211-218, 2001
47. Dyer PH, Chowdhury TA, Dronsfield MJ, Dunger D, Barnett AH, Bain SC: The 5′-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patients. Diabetologia 42:1030-1031, 1999
48. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS: Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabet Med 17:111-118, 2000
49. Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A: Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in type 1 and type 2 diabetes mellitus. Diabet Med 18:906-914, 2001
50. Ng DP, Conn J, Chung SS, Larkins RG: Aldose reductase (AC)(n) microsatellite polymorphism and diabetic microvascular complications in Caucasian type 1 diabetes mellitus. Diabetes Res Clin Pract 52:21-27, 2001
51. Lajer M, Tarnow L, Fleckner J, Hansen BV, Edwards DG, Parving HH, Boel E: Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian type 1 diabetic patients. Diabet Med 21:867-873, 2004
52. Onuma T, Laffel LM, Angelico MC, Krolewski AS: Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 7:1075-1078, 1996
53. Chowdhury TA, Dyer PH, Kumar S, Gibson SP, Rowe BR, Davies SJ, Marshall SM, Morris PJ, Gill GV, Feeney S, Maxwell P, Savage D, Boulton AJ, Todd JA, Dunger D, Barnett AH, Bain SC: Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 47:278-280, 1998
54. Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS: APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 49:2190-2195, 2000
55. Hadjadj S, Gallois Y, Simard G, Bouhanick B, Passa P, Grimaldi A, Drouin P, Tichet J, Marre M: Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Nephrol Dial Transplant 15:1971-1976, 2000
56. Tarnow L, Stehouwer CD, Emeis JJ, Poirier O, Cambien F, Hansen BV, Parving HH: Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. Nephrol Dial Transplant 15:625-630, 2000
57. Westfall P, Young S: Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment. New York, John Wiley & Sons, 1993
58. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53:784-794, 2004
59. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
60. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420, 1991
61. Yagame M, Kim Y, Zhu D, Suzuki D, Eguchi K, Nomoto Y, Sakai H, Groppoli T, Steffes MW, Mauer SM: Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70:42-48, 1995
62. Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373, 2003
63. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H: Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52:2586-2593, 2003
64. Guler S, Cakir B, Demirbas B, Yonem A, Odabasi E, Onde U, Aykut O, Gursoy G: Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Horm Res 58:67-70, 2002
65. Jin DK, Fish AJ, Wayner EA, Mauer M, Setty S, Tsilibary E, Kim Y, Anderson SS: Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol 7:2636-2645, 1996
66. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Ren Physiol Biochem 17:316-325, 1994
67. Narumi S, Onozato ML, Tojo A, Sakamoto S, Tamatani T: Tissue-specific induction of E-selectin in glomeruli is augmented following diabetes mellitus. Nephron 89:161-171, 2001
68. Hansen PM, Chowdhury T, Deckert T, Hellgren A, Bain SC, Pociot F: Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene): association with urinary albumin excretion in IDDM patients. Diabetes 46:1658-1659, 1997
69. Liu L, Xiang K, Zheng T, Zhang R, Li M, Wang Y, Lu H, Li J: The heparan sulfate proteoglycan gene polymorphism: association with type 2 diabetic nephropathy in Chinese. Mol Cell Biochem 245:121-126, 2003
70. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G: Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52:1023-1030, 2003
71. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de Heer E, Bruijn JA: Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 43:636-650, 2004
72. Kamiuchi K, Hasegawa G, Obayashi H, Kitamura A, Ishii M, Yano M, Kanatsuna T, Yoshikawa T, Nakamura N: Leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. J Diabetes Complicat 16:333-337, 2002
73. Zhang H, Jia Y, Cooper JJ, Hale T, Zhang Z, Elbein SC: Common variants in glutamine:fructose-6-phosphate amidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels. J Clin Endocrinol Metab 89:748-755, 2004
74. Tarnow L, Grarup N, Hansen T, Parving HH, Pedersen O: Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant 16:1653-1656, 2001
75. Ng DP, Canani L, Araki S, Smiles A, Moczulski D, Warram JH, Krolewski AS: Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 51:2264-2269, 2002
76. Hodgkinson AD, Millward BA, Demaine AG: Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. Kidney Int 59:985-989, 2001
77. Itoh Y, Imamura S, Yamamoto K, Ono Y, Nagata M, Kobayashi T, Kato T, Tomita M, Nakai A, Itoh M, Nagasaka A: Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate. J Endocrinol 175:233-239, 2002
78. Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IG: Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J 17:1514-1516, 2003
79. Kohan DE: Endothelins in the normal and diseased kidney. Am J Kidney Dis 29:2-26, 1997
80. Nabika T, Bonnardeaux A, James M, Julier C, Jeunemaitre X, Corvol P, Lathrop M, Soubrier F: Evaluation of the SA locus in human hypertension. Hypertension 25:6-13, 1995
81. Langham RG, Kelly DJ, Gow RM, Zhang Y, Dowling JK, Thomson NM, Gilbert RE: Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Am J Kidney Dis 44:826-831, 2004
82. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS: Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 31:627-631, 1998
83. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS: Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 27:1134-1139, 1996
84. Nannipieri M, Penno G, Pucci L, Colhoun H, Motti C, Bertacca A, Rizzo L, De Giorgio L, Zerbini G, Mangili R, Navalesi R: Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 10:1530-1541, 1999
85. Schmidt S, Bluthner M, Giessel R, Strojek K, Bergis KH, Grzeszczak W, Ritz E: A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group. Nephrol Dial Transplant 13:1807-1810, 1998
86. Roussel R, Tregouet DA, Hadjadj S, Jeunemaitre X, Marre M: Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes 53:1394-1398, 2004
87. Wang S, Hirschberg R: BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 284:F1006-F1013, 2003
88. Wang SN, Lapage J, Hirschberg R: Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12:2392-2399, 2001
89. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J: NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19:2505-2512, 2004
90. Wang S, Denichilo M, Brubaker C, Hirschberg R: Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60:96-105, 2001
91. Weston BS, Wahab NA, Mason RM: CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells. J Am Soc Nephrol 14:601-610, 2003
92. Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D: Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes 47:1341-1346, 1998
93. Mogyorosi A, Ziyadeh FN: Update on pathogenesis, markers and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 5:243-253, 1996
94. Lupia E, Elliot SJ, Lenz O, Zheng F, Hattori M, Striker GE, Striker LJ: IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 48:1638-1644, 1999
95. Sugimoto H, Shikata K, Makino H, Ota K, Ota Z: Upregulation of insulin-like growth factor receptor gene in experimental diabetic rat glomeruli. J Diabetes Complicat 9:262-264, 1995
96. Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M: Cellular basis of diabetic nephropathy: II. The transforming growth factor- system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 51:3577-3581, 2002
97. Nakagawa H, Sasahara M, Haneda M, Koya D, Hazama F, Kikkawa R: Immunohistochemical characterization of glomerular PDGF B-chain and PDGF [beta]-receptor expression in diabetic rats. Diabetes Res Clin Prac 48:87-98, 2000
98. Kim HW, Kim BC, Song CY, Kim JH, Hong HK, Lee HS: Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy. Kidney Int 66:1859-1865, 2004
99. Kelly DJ, Stein-Oakley A, Zhang Y, Wassef L, Maguire J, Koji T, Thomson N, Wilkinson-Berka JL, Gilbert RE: Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade. Nephrology 9:7-13, 2004
100. Hovind P, Tarnow L, Oestergaard PB, Parving HH: Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int 75 (Suppl.)S56-S61, 2000
101. Onozaki A, Midorikawa S, Sanada H, Hayashi Y, Baba T, Katoh T, Watanabe T: Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione. Biochem Biophys Res Commun 317:24-29, 2004
102. Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T, Kawamori R: RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 26:892-898, 2003
103. Tarnow L, Pociot F, Hansen PM, Rossing P, Nielsen FS, Hansen BV, Parving HH: Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 46:1075-1076, 1997
104. Loughrey BV, Maxwell AP, Fogarty DG, Middleton D, Harron JC, Patterson CC, Darke C, Savage DA: An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 10:984-988, 1998
105. Bensen JT, Langefeld CD, Hawkins GA, Green LE, Mychaleckyj JC, Brewer CS, Kiger DS, Binford SM, Colicigno CJ, Allred DC, Freedman BI, Bowden DW: Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster. Genomics 82:194-217, 2003
106. Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97:369-374, 1996
107. Ng DP, Warram JH, Krolewski AS: TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis 41:22-28, 2003
108. Wong TY, Poon P, Chow KM, Szeto CC, Cheung MK, Li PK: Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int 63:1831-1835, 2003
109. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146, 1995
110. Mattu RK, Trevelyan J, Needham EW, Khan M, Adiseshiah MA, Richter D, Murray RG, Betteridge DJ: Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in type II diabetes. Diabetologia 45:905-913, 2002
111. Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 44:929-935, 1995
112. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S: Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A 97:8157-8162, 2000
113. Sun L, Pan X, Wada J, Haas CS, Wuthrich RP, Danesh FR, Chugh SS, Kanwar YS: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy. J Biol Chem 277:29953-29962, 2002
114. Bluthner M, Bruntgens A, Schmidt S, Strojek K, Grzeszczak W, Ritz E: Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Nephrol Dial Transplant 14:56-57, 1999
115. Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS: Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes. Am J Kidney Dis 41:1189-1194, 2003
116. Smyth JS, Savage DA, Maxwell AP: MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes. Lancet 353:1156-1157, 1999
117. Weekers L, Hadjadj S, Belloum R, YG, Bouhanick B, MM: Lack of contribution of two endothelial nitric-oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes. Diabetologia 42 (Suppl. 1):A266, 1999
118. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405-413, 2000
119. Degen B, Schmidt S, Ritz E: A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant 16:185, 2001
120. Ng DP, Warram JH, Krolewski AS: To: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428.
121. Diabetologia 46:1706, 2003
122. Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC: Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428, 2003
123. Chiarelli F, Pomilio M, Mohn A, Tumini S, Verrotti A, Mezzetti A, Cipollone F, Wasniewska M, Morgese G, Spagnoli A: Serum angiogenin concentrations in young patients with diabetes mellitus. Eur J Clin Invest 32:110-114, 2002
124. De Cosmo S, Argiolas A, Miscio G, Thomas S, Piras GP, Trevisan R, Perin PC, Bacci S, Zucaro L, Margaglione M, Frittitta L, Pizzuti A, Tassi V, Viberti GC, Trischitta V: A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes 49:521-524, 2000
125. De Cosmo S, Miscio G, Zucaro L, Margaglione M, Argiolas A, Thomas S, Piras G, Trevisan R, Perin PC, Bacci S, Frittitta L, Pizzuti A, Tassi V, Di Minno G, Viberti G, Trischitta V: The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. Nephrol Dial Transplant 17:1402-1407, 2002
126. Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O: PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients. Nephrol Dial Transplant 17:1408-1412, 2002
127. Canani LH, Ng DP, Smiles A, Rogus JJ, Warram JH, Krolewski AS: Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 51:1188-1193, 2002
128. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T: Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 278:18229-18234, 2003
129. Nakamura T, Ebihara I, Tomino Y, Koide H: Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int 47:481-489, 1995
130. Khan MA, Dashwood MR, Mumtaz FH, Thompson CS, Mikhailidis DP, Morgan RJ: Upregulation of endothelin A receptor sites in the rabbit diabetic kidney: potential relevance to the early pathogenesis of diabetic nephropathy. Nephron 83:261-267, 1999
131. Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, Bonventre JV, Kyriakis JM: Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK: a potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy: possible role in the response to persistent stress. J Biol Chem 275:17838-17847, 2000
132. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H: Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int 56:1737-1750, 1999
133. Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, Meier M, Gueler F, Fiebeler A, Bahlmann FH, Leitges M, Haller H: Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53:2101-2109, 2004
134. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN: Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 296:1356-1365, 2002
135. Song Y, Ailenberg M, Silverman M: Cloning of a novel gene in the human kidney homologous to rat munc13s: its potential role in diabetic nephropathy. Kidney Int 53:1689-1695, 1998
136. Maltais I, Bachvarova M, Maheux P, Perron P, Marceau F, Bachvarov D: Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Can J Physiol Pharmacol 80:323-327, 2002
137. Zychma MJ, Gumprecht J, Zukowska-Szczechowska E, Grzeszczak W: Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test: the End-Stage Renal Disease Study Group. J Am Soc Nephrol 10:2120-2124, 1999
138. Kakoki M, Takahashi N, Jennette JC, Smithies O: Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A 101:13302-13305, 2004
139. Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E: Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: the Berlin Diabetes Mellitus (BeDiaM) study. Diabetes 51:2653-2657, 2002
140. Caramori ML, Canani LH, Costa LA, Gross JL: The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes 52:3010-3013, 2003
141. Sugawara F, Yamada Y, Watanabe R, Ban N, Miyawaki K, Kuroe A, Hamasaki A, Ikeda H, Kurose T, Usami M, Ikeda M, Seino Y: The role of the TSC-22 (-396) A/G variant in the development of diabetic nephropathy. Diabetes Res Clin Pract 60:191-197, 2003
142. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG: The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 52:846-851, 2003
143. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H: Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 46:1428-1437, 2003
144. Agre P, Kozono D: Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 555:72-78, 2003
145. Trevisan R, Viberti G: Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy. Nephrol Dial Transplant 12:643-645, 1997
146. Zerbini G, Gabellini D, Ruggieri D, Maestroni A: Increased sodium-lithium countertransport activity: a cellular dysfunction common to essential hypertension and diabetic nephropathy. J Am Soc Nephrol 15 (Suppl. 1):S81-S84, 2004
147. Tanaka N, Babazono T, Saito S, Sekine A, Tsunoda T, Haneda M, Tanaka Y, Fujioka T, Kaku K, Kawamori R, Kikkawa R, Iwamoto Y, Nakamura Y, Maeda S: Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 52:2848-2853, 2003
148. Anwar W, Gerard P, Moutabarrek A, Namour F, Gueant J-L: End-stage renal disease increases plasma transcobalamin and neutralizes influence of TCN 776C>G polymorphism. Kidney Int 66:2092-2093, 2004
149. Murata I, Takemura G, Asano K, Sano H, Fujisawa K, Kagawa T, Baba K, Maruyama R, Minatoguchi S, Fujiwara T, Fujiwara H: Apoptotic cell loss following cell proliferation in renal glomeruli of Otsuka Long-Evans Tokushima Fatty rats, a model of human type 2 diabetes. Am J Nephrol 22:587-595, 2002
150. Kang BP, Urbonas A, Baddoo A, Baskin S, Malhotra A, Meggs LG: IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose. Am J Physiol Renal Physiol 285:F1013-F1024, 2003
151. Li H, Telemaque S, Miller RE, Marsh JD: High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes 54:540-545, 2005
152. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC: Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170-2177, 2000
153. McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, Godson C, Martin F, Brady HR: IHG-2, a mesangial cell gene induced by high glucose, is human gremlin: regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem 275:9901-9904, 2000
154. Conway BR, Maxwell AP, Savage DA, Patterson CC, Doran PP, Murphy M, Brady HR, Fogarty DG: Association between variation in the actin-binding gene caldesmon and diabetic nephropathy in type 1 diabetes. Diabetes 53:1162-1165, 2004